Concepedia

Kevin Daly

KD

8

Publications

246

Citations

8

H-Index

1975

Active since

Affiliations

California State University, Northridge(Current)

AstraZeneca (United States)

AstraZeneca (United Kingdom)

Kevin Daly is an author at California State University, Northridge specializing in medicine, natural sciences, and drug discovery.

Top concepts

Publications per year

1975–2015

8

Publications

8

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering

Jeffrey W. Johannes, Lynsie Almeida, Kevin Daly et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 62 citations · Full text

, , +5

Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitors

James W. Janetka, Lynsie Almeida, Susan Ashwell et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 37 citations · Full text

, , +10

Isolation, characterization, and numerical taxonomy of Simonsiella strains from the oral cavities of cats, dogs, sheep, and humans

Daisy A. Kuhn, David A. Gregory, Gordon E. Buchanan et al. · Archives of Microbiology · 1978 · 33 citations

, , +11

Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507

David A. Scott, Les A. Dakin, Kevin Daly et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 30 citations · Full text

, , +6

Selection associated with the alcohol dehydrogenase locus in Drosophila melanogaster: Differential survival of adults maintained on low concentrations of ethanol

Kevin Daly, Bryan Clarke · Heredity · 1981 · 26 citations · Full text

, , +11

Rows per page

1–5 of 8